The fight against cancer in the country has received another major boost after Nairobi West Hospital announced that it had ...

A newly developed PET radiotracer has shown the ability to produce high-quality images of real-time brain inflammation, ...

When 64-year-old MBK Nair first noticed a subtle tremor in his right hand in 2020, he brushed it off as fatigue or muscle weakness, assuming that could be a sig ...

GE HealthCare’s commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on ...

Telix Pharmaceuticals has introduced a new positron emission tomography (PET) radiochemistry solution, AlFluor, based on ...

At this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the ...

Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with ...

Merrill H. Stewart, MD, Ochsner Health, outlines the financial, logistical, and reimbursement barriers slowing the adoption of cardiac stress testing, but growing recognition of its long-term value ...

The largest public sector healthcare facility in Pakistan, the Jinnah Postgraduate Medical Centre in Karachi, provides ...

Illuccix, after radiolabelling with gallium-68, is indicated in Greece for the detection of prostate-specific membrane ...

PYLARIFY has made a profound impact on the lives of patients battling prostate cancer. It is the number one ordered PSMA PET imaging agent in the U.S., and is a proven diagnostic backed by real-world ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging 1 agent for prostate cancer, Gozellix® (kit for the preparation ...